Au service des municipalités, des industries et des communautés autochtones de l'Ontario
EN FR
📞 +1 (613) 883-5905 — P.Eng. répond sous 1 jour ouvrable

Industrie

Traitement des eaux usées pharmaceutiques

Élimination des API, destruction des antibiotiques et conformité aux exigences de la FDA et de l'EPA pour la fabrication pharmaceutique.

🤖 Aperçu IA

Les eaux usées pharmaceutiques contiennent des ingrédients pharmaceutiques actifs (IPA), des antibiotiques, des solvants et une DCO élevée qui nécessitent un traitement spécialisé au-delà des procédés biologiques conventionnels. BioTerraVa conçoit des systèmes d'oxydation avancée et biologiques qui assurent >99 % d'élimination des IPA et la conformité aux normes de rejet de l'industrie pharmaceutique.

Défis industriels

Pharmaceutical Effluent Challenges

Pharmaceutical manufacturing generates complex wastewater with high COD, toxic organics, and biologically active compounds that can disrupt conventional treatment and create environmental risks.

  • High COD (1,000-10,000 mg/L) from solvents and organic intermediates
  • Antibiotics and APIs toxic to biological treatment systems
  • Variable batch discharges creating treatment surges
  • Low biodegradability of many pharmaceutical compounds
  • Stringent FDA and EPA discharge requirements

Solutions BioTerraVa

Pharmaceutical Wastewater Solutions

BioTerraVa designs pharmaceutical wastewater treatment systems that combine advanced oxidation for API and antibiotic destruction with biological treatment for COD removal. Our designs include equalization for batch discharge buffering and specialized monitoring for compliance verification.

  • Equalization and pH adjustment for batch discharge buffering
  • Advanced oxidation (ozone, UV/H2O2, Fenton) for API and antibiotic destruction
  • Biological treatment (MBBR or MBR) for COD/BOD removal
  • Activated carbon adsorption for residual organics and micropollutants
  • Specialized analytical monitoring for API verification

Conformité

Pharmaceutical Industry Compliance

Pharmaceutical facilities must comply with EPA pharmaceutical effluent guidelines, FDA cGMP requirements, and state NPDES permits. Antibiotic discharge is of particular concern due to antimicrobial resistance risks.

  • EPA pharmaceutical effluent guidelines (40 CFR 439)
  • FDA cGMP requirements for wastewater handling
  • State NPDES permits with pharmaceutical-specific limits
  • Antibiotic discharge restrictions to prevent resistance
  • Industry voluntary guidelines (PhRMA, API standards)

Étude de cas

API Manufacturer Achieves >99% Antibiotic Removal

Problème : An API manufacturer in New Jersey was facing EPA enforcement for antibiotic discharge (>50 µg/L in effluent vs. detection limit target). The existing activated sludge system could not destroy antibiotics.

Solution : BioTerraVa designed: equalization + ozone AOP for antibiotic destruction + MBBR for COD removal + GAC adsorption for residual organics.

Résultats : Antibiotic concentration reduced from >50 µg/L to <0.1 µg/L (>99.8% removal). COD reduced from 3,200 to 180 mg/L (94% removal). Zero EPA violations in 24 months.

Obtenez une évaluation gratuite pour votre installation

Parlez avec un ingénieur principal au sujet de vos défis d'effluents spécifiques.

Réservez une consultation gratuite de 30 minutes →

Ressources connexes

Services

Technologies

FAQ

Questions fréquemment posées

How to remove antibiotics from wastewater?

Antibiotics are removed through advanced oxidation processes (ozone, UV/H2O2, Fenton's reagent) that break down their molecular structure. Conventional biological treatment is often ineffective because antibiotics are designed to resist bacterial degradation. BioTerraVa designs ozone-based AOP systems that achieve >99% antibiotic destruction while simultaneously reducing COD and improving biodegradability of other organics.

What is pharmaceutical wastewater treatment?

Pharmaceutical wastewater treatment is the specialized process of removing active pharmaceutical ingredients (APIs), antibiotics, solvents, and high organic loads from manufacturing effluent. Treatment typically involves: equalization, advanced oxidation for API destruction, biological treatment for COD removal, and adsorption for residual organics. Due to the toxicity of many pharmaceutical compounds to biological systems, advanced oxidation is usually required before biological treatment.

How to treat high COD pharmaceutical wastewater?

High COD pharmaceutical wastewater (1,000-10,000 mg/L) requires a combination of: (1) Equalization to buffer batch discharges, (2) Advanced oxidation to break down refractory compounds and improve biodegradability, (3) Biological treatment (anaerobic for high COD, aerobic for polishing), and (4) Activated carbon adsorption for residual organics. For COD >5,000 mg/L, anaerobic pre-treatment with biogas recovery is recommended. BioTerraVa's designs achieve >90% COD removal with antibiotic destruction >99%.

Parlez avec un P.Eng. qui fait cela depuis 36 ans

Domestique ou industriel, municipal ou communauté autochtone — la première consultation de 30 minutes est gratuite.

Réservez votre consultation gratuite →